Cevian Capital II GP LTD, a registered investment adviser, initiated a new position in UBS Group AG (NYSE:UBS) during Q4 2025, according to its most recent 13F filing with the…
Cevian Capital II GP LTD, a registered investment adviser, initiated a new position in UBS Group AG (NYSE:UBS) during Q4 2025, according to its most recent 13F filing with the Securities and Exchange Commission.
The institutional investor purchased 48,117,675 shares of the Financial Services company, valued at approximately $2.2B as of the filing date.
UBS Group AG's stock currently trades at $41.38 with a market capitalization of $135.7B.
Current market data
NYSE · UBS
$53.73
Down: -$0.20 · -0.37%
Live quote updated
Our Markets Team monitors market data, SEC filings, analyst actions, earnings releases, and corporate announcements to produce timely updates for investors.
Keep reading
institutional ·
institutional ·
institutional ·
price ·
